This list is an analysis based on recent market events. It's not an investment recommendation.
About
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
The current price of GRAL.BOATS is $71.67 USD — it has decreased by -0.46% in the past 24 hours. Watch GRAIL stock price performance more closely on the chart.
What is GRAIL stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange GRAIL stocks are traded under the ticker GRAL.BOATS.
What is GRAIL market cap?▼
Today GRAIL has the market capitalization of 3.08B
When is the next GRAIL earnings date?▼
GRAIL is going to release the next earnings report on August 18, 2026.
What were GRAIL earnings last quarter?▼
GRAL.BOATS earnings for the last quarter are -2.29 USD per share, whereas the estimation was -2.76 USD resulting in a +17.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GRAIL revenue for the last year?▼
GRAIL revenue for the last year amounts to 147.17M USD.
What is GRAIL net income for the last year?▼
GRAL.BOATS net income for the last year is -408.35M USD.